Olema Pharmaceuticals inc (OLMA)
8.74
-0.47
(-5.10%)
USD |
NASDAQ |
May 23, 16:00
8.74
0.00 (0.00%)
After-Hours: 19:03
Olema Pharmaceuticals Total Assets (Quarterly): 263.69M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 263.69M |
| December 31, 2023 | 276.94M |
| September 30, 2023 | 292.80M |
| June 30, 2023 | 177.62M |
| March 31, 2023 | 195.77M |
| December 31, 2022 | 215.64M |
| September 30, 2022 | 232.00M |
| June 30, 2022 | 250.60M |
| Date | Value |
|---|---|
| March 31, 2022 | 277.42M |
| December 31, 2021 | 295.94M |
| September 30, 2021 | 309.80M |
| June 30, 2021 | 322.23M |
| March 31, 2021 | 331.30M |
| December 31, 2020 | 342.72M |
| September 30, 2020 | 130.68M |
| December 31, 2019 | 0.132M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.132M
Minimum
Dec 2019
342.72M
Maximum
Dec 2020
244.71M
Average
270.32M
Median
Total Assets (Quarterly) Benchmarks
| Geron Corp | 482.07M |
| Verastem Inc | 123.54M |
| Fate Therapeutics Inc | 569.89M |
| Karyopharm Therapeutics Inc | 204.46M |
| Alpine Immune Sciences Inc | 373.65M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.38M |
| Shareholders Equity (Quarterly) | 236.32M |